Target intelligence / Profile preview

Extracellular matrix augmentation via viscoelastic support

Molecular classification
Other
01

Overview

Extracellular matrix augmentation via viscoelastic support describes a biomaterial or engineering strategy to enhance or restore tissue function by modifying the mechanical (viscoelastic) properties of the extracellular matrix. Rather than targeting a specific molecule, this approach involves designing hydrogels or scaffolds with tunable viscoelastic characteristics to regulate cell fate, enhance tissue repair or regeneration, or study cellular responses to mechanical environments. This has been shown to play key roles in tissue morphogenesis, stem cell differentiation, cancer progression, and other areas where mechanical cell-matrix interactions are critical. It does not refer to a single protein or receptor and cannot be mapped to classical drug target databases.

Other names
ECM viscoelasticity modulationenhanced viscoelastic ECM
02

Mechanism of action

Approaches that augment viscoelastic support act by: Physically altering ECM structure to regulate cell behavior through mechanotransduction, affecting nuclear architecture, gene expression, differentiation, and cell fate determination. Providing dynamic physical cues (stress relaxation, viscous/elastic balance) that better mimic natural tissue environments compared to static (purely elastic) matrices.

03

Biological functions

Cell proliferationCell differentiationCell migrationCell adhesionTissue morphogenesis and regeneration
04

Disease associations

Cancer (tumor progression and microenvironment)FibrosisTissue regeneration and repairOther (aging-related changes, metabolic disease effects)
05

Safety considerations

Possible foreign body response to biomaterialsRisk of inducing fibrosis or aberrant tissue growth if mechanical properties are not carefully matched to native tissuePotential promotion of tumor progression in cancer contexts if increased ECM viscoelasticity supports malignant cell migration/invasion
06

Interacting drugs

Some biomaterials or biophysical therapies (such as hydrogels, injectable polymers, scaffolds) deliberately modify ECM viscoelastic properties to influence tissue repair, regeneration, or cellular reprogramming

1 more in the full profile.

07

Biomarkers

Nuclear remodeling genes (e.g., lamin A/C levels)Chromatin accessibility/epigenetic marksCell differentiation markers, depending on tissue contextMechanical property measurements (rheometry of tissues)

Beyond the preview

Go deeper on Extracellular matrix augmentation via viscoelastic support.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Extracellular matrix augmentation via viscoelastic support.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call